RA Capital Management

Ra Capital Management as of June 30, 2024

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 78 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A/s - SH (ASND) 18.2 $1.4B 10M 136.38
Vaxcyte SH (PCVX) 8.2 $620M 8.2M 75.51
Janux Therapeutics SH (JANX) 5.1 $384M 9.2M 41.89
Legend Biotech Corp- SH (LEGN) 4.4 $333M 7.5M 44.29
Rhythm Pharmaceuticals SH (RYTM) 3.3 $250M 6.1M 41.06
Biogen SH (BIIB) 3.0 $228M 982k 231.82
Eliem Therapeutics SH (ELYM) 3.0 $223M 31M 7.11
Rxsight SH (RXST) 2.9 $222M 3.7M 60.17
Avidity Biosciences SH (RNA) 2.9 $221M 5.4M 40.85
Dyne Therapeutics SH (DYN) 2.8 $214M 6.0M 35.29
Geron Corp SH (GERN) 2.6 $196M 46M 4.24
Pepgen SH (PEPG) 2.3 $171M 11M 15.96
Tyra Biosciences SH (TYRA) 2.2 $167M 10M 15.99
Evolent Health Inc - A SH (EVH) 2.2 $163M 8.5M 19.12
Edgewise Therapeutics SH (EWTX) 2.1 $161M 8.9M 18.01
Newamsterdam Pharma Co Nv SH (NAMS) 2.0 $155M 8.1M 19.21
Recursion Pharmaceuticals-a SH (RXRX) 1.5 $115M 15M 7.50
89bio SH (ETNB) 1.5 $114M 14M 8.01
Verona Pharma Plc - SH (VRNA) 1.5 $110M 7.6M 14.46
Day One Biopharmaceuticals I SH (DAWN) 1.4 $109M 7.9M 13.78
4d Molecular Therapeutics In SH (FDMT) 1.4 $107M 5.1M 20.99
Ars Pharmaceuticals SH (SPRY) 1.2 $92M 11M 8.51
Wave Life Sciences SH (WVE) 1.2 $91M 18M 4.99
Longboard Pharmaceuticals In SH (LBPH) 1.2 $89M 3.3M 27.03
Arcellx SH (ACLX) 1.2 $89M 1.6M 55.19
Axsome Therapeutics SH (AXSM) 1.1 $81M 1.0M 80.50
Apogee Therapeutics SH (APGE) 1.0 $77M 2.0M 39.35
Gh Research SH (GHRS) 1.0 $77M 6.6M 11.66
Structure Therapeutics SH (GPCR) 1.0 $75M 1.9M 39.27
Lenz Therapeutics SH (LENZ) 1.0 $72M 4.2M 17.29
Fulcrum Therapeutics SH (FULC) 1.0 $72M 12M 6.20
Nkarta SH (NKTX) 0.8 $64M 11M 5.91
Dianthus Therapeutics SH (DNTH) 0.8 $60M 2.3M 25.88
Mineralys Therapeutics SH (MLYS) 0.8 $57M 4.9M 11.70
Iteos Therapeutics SH (ITOS) 0.7 $52M 3.5M 14.84
Urogen Pharma SH (URGN) 0.7 $52M 3.1M 16.78
Praxis Precision Medicines I SH (PRAX) 0.7 $51M 1.2M 41.36
Enliven Therapeutics SH (ELVN) 0.7 $50M 2.1M 23.37
Acrivon Therapeutics SH (ACRV) 0.6 $48M 8.3M 5.80
Astria Therapeutics SH (ATXS) 0.6 $46M 5.0M 9.10
Bicycle Therapeutics Plc- SH (BCYC) 0.6 $46M 2.3M 20.24
Cg Oncology SH (CGON) 0.6 $44M 1.4M 31.57
Larimar Therapeutics SH (LRMR) 0.6 $44M 6.0M 7.25
Acumen Pharmaceuticals SH (ABOS) 0.5 $36M 15M 2.42
Tourmaline Bio SH (TRML) 0.4 $33M 2.5M 12.86
Third Harmonic Bio SH (THRD) 0.3 $26M 2.0M 13.00
Solid Biosciences SH (SLDB) 0.3 $25M 4.3M 5.67
Taysha Gene Therapies SH (TSHA) 0.3 $24M 11M 2.24
Tenaya Therapeutics SH (TNYA) 0.3 $24M 7.6M 3.10
Vor Biopharma SH (VOR) 0.3 $23M 23M 1.00
C4 Therapeutics SH (CCCC) 0.3 $23M 4.9M 4.62
Alto Neuroscience SH (ANRO) 0.3 $22M 2.1M 10.69
Immatics Nv SH (IMTX) 0.3 $20M 1.8M 11.62
Sera Prognostics Inc-a SH (SERA) 0.2 $18M 3.0M 5.92
Aerovate Therapeutics SH (AVTE) 0.2 $15M 9.2M 1.66
Werewolf Therapeutics SH (HOWL) 0.2 $15M 6.1M 2.44
Cervomed SH (CRVO) 0.2 $14M 817k 17.12
Pliant Therapeutics SH (PLRX) 0.2 $14M 1.3M 10.75
Nurix Therapeutics SH (NRIX) 0.2 $14M 650k 20.87
Insmed SH (INSM) 0.2 $13M 200k 67.00
An2 Therapeutics SH (ANTX) 0.2 $12M 5.6M 2.15
Cybin SH (CYBN) 0.2 $12M 44M 0.27
Zura Bio SH (ZURA) 0.1 $11M 3.2M 3.50
Arvinas SH (ARVN) 0.1 $11M 421k 26.62
Regulus Therapeutics SH (RGLS) 0.1 $11M 6.3M 1.78
Lexeo Therapeutics SH (LXEO) 0.1 $11M 673k 16.04
Adicet Bio SH (ACET) 0.1 $9.1M 7.5M 1.21
Nuvalent Inc-a SH (NUVL) 0.1 $9.1M 120k 75.86
Macrogenics SH (MGNX) 0.1 $8.8M 2.1M 4.25
Boundless Bio SH (BOLD) 0.1 $8.4M 2.2M 3.87
Chimerix SH (CMRX) 0.1 $7.7M 8.8M 0.88
Perceptive Capital Solutions SH (PCSC) 0.1 $7.5M 750k 10.06
Metagenomi SH (MGX) 0.1 $6.0M 1.5M 4.08
Protara Therapeutic SH (TARA) 0.1 $4.0M 1.9M 2.08
Surrozen SH (SRZN) 0.0 $3.1M 283k 10.95
Newamsterdam Pharma Co Nv-27 SH (NAMSW) 0.0 $2.9M 333k 8.72
Unicycive Therapeutics SH (UNCY) 0.0 $1.3M 2.6M 0.50
Scilex Holding SH (SCLX) 0.0 $504k 261k 1.93